PPARG and cholangiocarcinoma: This could occur due to different methylation level [39]. PPAR-γ encodes a nuclear receptor controlling ligand-activated transcription factor. PPAR-γ is overexpressed in a number of cancers, including HCC, pancreatic cancer, and CCA [40].